Skip to main content
. 2021 Aug 17;16:57. doi: 10.1186/s13027-021-00396-x

Table 4.

Treatment response between GCB subgroup and non-GCB subgroups in HBsAg-positive and -negative DLBCL patients

Treatment response HBsAg-positive patients HBsAg-negative patients
GCB (n = 47) non-GCB (n = 79) P-Value GCB (n = 107) non-GCB (n = 186) P value
CR/CRu 42 46 0.252 73 123 0.718
PR 15 27 29 54
SD 0 1 2 2
PD 3 5 3 7

CR complete response, PR partial response, SD stable disease, PD progressive disease